Cabaletta Bio Stock (NASDAQ: CABA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.18M |
Day Range | - - - |
52 Wk Range | 3.47 - 26.35 |
Market Cap | $233.99M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 13.51% |
Days to Cover | 6.73 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cabaletta Bio (NASDAQ:CABA) through any online brokerage.
Other companies in Cabaletta Bio’s space includes: Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), Atossa Therapeutics (NASDAQ:ATOS), Adaptimmune Therapeutics (NASDAQ:ADAP) and Sangamo Therapeutics (NASDAQ:SGMO).
Cabaletta Bio has a consensus price target of $26.85.
The stock price for Cabaletta Bio (NASDAQ: CABA) is $4.79 last updated September 20, 2024 at 5:01 PM EDT.
There are no upcoming dividends for Cabaletta Bio.
Cabaletta Bio’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Cabaletta Bio.
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.